Filing Flows

Filing Flows › Insmed (INSM) › Next earnings date

Insmed (INSM) earnings: missed the estimate

Insmed (INSM) reported on Oct 29, 2026 and missed the EPS estimate: −$0.46 against −$0.37 (-23.7%). Revenue was $524M for Q3 2026, +268% year over year. It beat the EPS estimate in 40% of the quarters on record.

Last result−23.7% vs estimate
Beat rate40%

The last report

Insmed reported revenue of $524M for the third quarter 2026 (+268% Y/Y), net loss $100M: BRINSUPRI $400M, ARIKAYCE $124M. How it makes money → · Every quarter →

Insmed: EPS against the estimate, last 5 reportsInsmed: EPS against the estimate, last 5 reportsEstimateReported−$1.37−$1.75Oct 25−$1.17−$1.54Feb 26−$1.00−$0.76May 26−$0.68−$0.06Aug 26−$0.37−$0.46Oct 26
Latest (Oct 26): Estimate −$0.37, Reported −$0.46.
INSM: the stock's move on each reportINSM: the stock's move on each reportAug 6, 2026+32.4%May 7, 2026-26.1%Feb 19, 2026+9.1%Oct 30, 2025+13.6%

Insmed's latest quarter

Insmed, Q3 2026: revenue $524M (+268% year over year), operating margin -17.0%, net loss $100M, operating cash flow −$36.5M. The chart follows the revenue to costs, profit and cash.

Questions

Did Insmed beat earnings?

Insmed (INSM) reported on Oct 29, 2026 and missed the EPS estimate: −$0.46 against −$0.37 (-23.7%).

When does INSM report earnings?

The next date is not set yet.

Does Insmed usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.